The Pentagon has introduced new guidelines requiring mandatory testosterone testing for male military personnel aged 30 and older. This policy, which does not currently apply to women, has sparked debate among medical professionals about its necessity and effectiveness. Defense Secretary Pete Hegseth announced in July that the initiative aims to ensure service members are operating at their "absolute best" by identifying and addressing "testosterone deficiency." The updated clinical guidance, released recently, outlines how the screening program will be implemented. The push for testosterone testing aligns with a growing public interest in the hormone, fueled in part by health influencers and podcasters who often promote testosterone supplements as a way to increase energy, muscle mass, and a sense of youthfulness. However, many medical experts argue that these benefits are not well-supported by scientific research. Hegseth’s statements on the topic have combined scientifically backed information with broader, less proven claims, adding to the controversy. The new guidance clarifies that the mandatory testing applies only to male service members. While Hegseth initially proposed screening for all troops, the latest document specifies that it is for "testosterone deficiency in the male service member." The guidance notes that guidelines for female service members are still under review. It remains unclear whether female troops will be eligible for estrogen-based therapy as they enter perimenopause, a phase marked by declining estrogen levels. Testosterone naturally declines with age and can affect sexual function, mood, and bone density. However, medical experts have long debated the best ways to diagnose and treat these issues. Federal studies in recent years have shown that testosterone replacement can help with erectile dysfunction and low libido in men. Despite this, medical organizations generally advise against routine screening for testosterone levels. Instead, they recommend testing only for men who report symptoms and have confirmed low hormone levels through two blood tests. The Pentagon’s approach differs from standard medical practices by requiring all male service members over 30 to undergo screening, though younger members can also request it. The new guidelines largely follow medical standards, acknowledging the limited benefits of testosterone replacement. They state that there is no evidence supporting its use to improve energy, vitality, or cognitive function, but note benefits for sexual function and bone density. The policy does not require replacement therapy for those found eligible, and it highlights potential side effects, such as reduced sperm count, which could impact military personnel planning to have children. Another challenge is the management of testosterone in a military setting. The guidelines note that using testosterone in deployed environments raises concerns about storage, supply, and accountability. Injectable testosterone, for example, requires controlled storage and careful handling. Service members on replacement therapy must ensure they have enough medication, as federal laws restrict prescriptions for controlled substances like testosterone. This practical complexity contrasts with Hegseth’s earlier statements, in which he emphasized the need for "maximum psychological and mental readiness" on the battlefield and suggested that testosterone therapy could be part of the solution.